Cargando…

Responses to Environmental Enrichment Differ with Sex and Genotype in a Transgenic Mouse Model of Huntington's Disease

BACKGROUND: Environmental enrichment (EE) in laboratory animals improves neurological function and motor/cognitive performance, and is proposed as a strategy for treating neurodegenerative diseases. EE has been investigated in the R6/2 mouse model of Huntington's disease (HD), where increased s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wood, Nigel I., Carta, Valentina, Milde, Stefan, Skillings, Elizabeth A., McAllister, Catherine J., Ang, Y.L. Mabel, Duguid, Alasdair, Wijesuriya, Nadeev, Afzal, Samira Mohd, Fernandes, Joe X., Leong, T.W., Morton, Jennifer
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820540/ https://www.ncbi.nlm.nih.gov/pubmed/20174443 http://dx.doi.org/10.1371/journal.pone.0009077

Ejemplares similares

Correction: Responses to Environmental Enrichment Differ with Sex and Genotype in a Transgenic Mouse Model of Huntington's Disease
por: Wood, Nigel I., et al.
Publicado: (2010)

Beneficial effects of environmental enrichment and food entrainment in the R6/2 mouse model of Huntington's disease
por: Skillings, Elizabeth A, et al.
Publicado: (2014)

Antagonistic pleiotropy in mice carrying a CAG repeat expansion in the range causing Huntington’s disease
por: Morton, A. J., et al.
Publicado: (2019)

Phosphoproteomic dysregulation in Huntington’s disease mice is rescued by environmental enrichment
por: Mees, Isaline, et al.
Publicado: (2022)

The Role of the Electrophysiologist in Convergent Ablation
por: Wijesuriya, Nadeev, et al.
Publicado: (2020)

Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease
por: McAllister, Branduff, et al.
Publicado: (2021)

Temporal Separation of Aggregation and Ubiquitination during Early Inclusion Formation in Transgenic Mice Carrying the Huntington’s Disease Mutation
por: Gong, Belvin, et al.
Publicado: (2012)

Prolonged day length exposure improves circadian deficits and survival in a transgenic mouse model of Huntington's disease
por: Ouk, Koliane, et al.
Publicado: (2016)

Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
por: Chen, Xi, et al.
Publicado: (2011)

Lessons Learned from the Transgenic Huntington's Disease Rats
por: Vlamings, Rinske, et al.
Publicado: (2012)

Increase in right ventricular lead pacing threshold following stereotactic ablative therapy for ventricular tachycardia
por: Wijesuriya, Nadeev, et al.
Publicado: (2023)

Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model
por: Jiang, Wenxiao, et al.
Publicado: (2015)

Metabolic disruption identified in the Huntington’s disease transgenic sheep model
por: Handley, Renee. R., et al.
Publicado: (2016)

Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
por: Chang, Renbao, et al.
Publicado: (2015)

Striatal Interneurons in Transgenic Nonhuman Primate Model of Huntington’s Disease
por: Lallani, Shoeb B., et al.
Publicado: (2019)

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
por: Henningsen, Jo B., et al.
Publicado: (2021)

Leadless Pacing: Therapy, Challenges and Novelties
por: Wijesuriya, Nadeev, et al.
Publicado: (2023)

Multi-lead pacing for cardiac resynchronization therapy in heart failure: a meta-analysis of randomized controlled trials
por: Elliott, Mark K, et al.
Publicado: (2022)

microRNA-128a dysregulation in transgenic Huntington’s disease monkeys
por: Kocerha, Jannet, et al.
Publicado: (2014)

Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington’s disease monkeys
por: Kocerha, Jannet, et al.
Publicado: (2013)

Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration
por: Ardan, Taras, et al.
Publicado: (2019)

Ataxic Symptoms in Huntington’s Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone
por: Egorova, Polina A., et al.
Publicado: (2020)

Mutant huntingtin confers cell-autonomous phenotypes on Huntington’s disease iPSC-derived microglia
por: Stöberl, Nina, et al.
Publicado: (2023)

Leadless Cardiac Pacing: New Horizons
por: Malaczynska-Rajpold, Katarzyna, et al.
Publicado: (2022)

Intellectual enrichment and genetic modifiers of cognition and brain volume in Huntington’s disease
por: Papoutsi, Marina, et al.
Publicado: (2022)

Altered diffusion tensor imaging measurements in aged transgenic Huntington disease rats
por: Antonsen, Bjørnar T., et al.
Publicado: (2012)

A two years longitudinal study of a transgenic Huntington disease monkey
por: Chan, Anthony WS, et al.
Publicado: (2014)

Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease
por: Czeredys, Magdalena, et al.
Publicado: (2013)

Developmental Whole Brain White Matter Alterations in Transgenic Huntington’s Disease Monkey
por: Meng, Yuguang, et al.
Publicado: (2017)

Transvenous lead extraction in conduction system pacing
por: Wijesuriya, Nadeev, et al.
Publicado: (2022)

The role of conduction system pacing in patients with atrial fibrillation
por: Wijesuriya, Nadeev, et al.
Publicado: (2023)

Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
por: Lobanov, Sergey V., et al.
Publicado: (2022)

Leadless Left Bundle Branch Area Pacing in Cardiac Resynchronisation Therapy: Advances, Challenges and Future Directions
por: Wijesuriya, Nadeev, et al.
Publicado: (2022)

Rate or Rhythm Control in CRT (RHYTHMIC): Study rationale and protocol
por: Elliott, Mark K., et al.
Publicado: (2022)

Voxel-based morphometry with templates and validation in a mouse model of Huntington’s disease()
por: Sawiak, Stephen J., et al.
Publicado: (2013)

Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
por: Petersén, Åsa, et al.
Publicado: (2005)

Circadian Abnormalities in Motor Activity in a BAC Transgenic Mouse Model of Huntington’s Disease
por: Oakeshott, Stephen, et al.
Publicado: (2011)

Genome-Wide Histone Acetylation Is Altered in a Transgenic Mouse Model of Huntington's Disease
por: McFarland, Karen N., et al.
Publicado: (2012)

Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington disease
por: Faure, Alexis, et al.
Publicado: (2013)

Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease
por: de Paula Nascimento-Castro, Cristine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3mm47tpbkqrq2je49nb09otvkb